SB 2075
6 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Bayer U.S. LLC | Lobbied on it | Bayer U.S. LLC named SB 2075 in 2 lobbying reports. | 2 reports |
| Amgen | Lobbied on it | Amgen named SB 2075 in 1 lobbying report. | 1 report |
| Baxter Healthcare Corporation | Lobbied on it | Baxter Healthcare Corporation named SB 2075 in 1 lobbying report. | 1 report |
| California Life Sciences | Lobbied on it | California Life Sciences named SB 2075 in 1 lobbying report. | 1 report |
| Multistate Associates Inc. on Behalf of National Wholesale Druggists' Association | Lobbied on it | Multistate Associates Inc. on Behalf of National Wholesale Druggists' Association named SB 2075 in 1 lobbying report. | 1 report |
| Pharmaceuticals: price regulation. | Source records | SB 2075 has an explicit source reference to Pharmaceuticals: price regulation.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…